Literature DB >> 29184470

Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique.

Miranda Kusters1,2, Keisuke Uehara3, Cornelis J H van de Velde2, Yoshihiro Moriya4.   

Abstract

Nodal dissemination in locally advanced rectal cancer occurs mainly in two directions: upward and lateral. Lateral node involvement has been demonstrated; however, lateral lymph node dissection (LLND) is not routinely performed in Western countries and the focus is more on neoadjuvant treatment regimens. The main reasons for this are the high morbidity associated with the operation and the uncertain oncological benefit. There is, however, recent evidence that in selected cases, neoadjuvant treatment combined with total mesorectal excision only might not be sufficient. In this article, the historical developments in the East and the West, the current evidence regarding lateral nodal disease, and the surgical steps in the LLND are discussed.

Entities:  

Keywords:  lateral nodes; local recurrence; rectal cancer

Year:  2017        PMID: 29184470      PMCID: PMC5703666          DOI: 10.1055/s-0037-1606112

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  40 in total

1.  Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum.

Authors:  M W STEARNS; M R DEDDISH
Journal:  Dis Colon Rectum       Date:  1959 Mar-Apr       Impact factor: 4.585

2.  Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis.

Authors:  I SAUER; H E BACON
Journal:  Am J Surg       Date:  1951-01       Impact factor: 2.565

3.  Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.

Authors:  E Kapiteijn; E K Kranenbarg; W H Steup; C W Taat; H J Rutten; T Wiggers; J H van Krieken; J Hermans; J W Leer; C J van de Velde
Journal:  Eur J Surg       Date:  1999-05

4.  Determination of the peritoneal reflection using intraoperative proctoscopy.

Authors:  Melissa M Najarian; G Eric Belzer; Thomas H Cogbill; Michelle A Mathiason
Journal:  Dis Colon Rectum       Date:  2004-12       Impact factor: 4.585

5.  The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study.

Authors:  A Martling; T Holm; H Johansson; L E Rutqvist; B Cedermark
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

6.  A prospective study on radical and nerve-preserving surgery for rectal cancer in the Netherlands.

Authors:  C P Maas; Y Moriya; W H Steup; E Klein Kranenbarg; C J van de Velde
Journal:  Eur J Surg Oncol       Date:  2000-12       Impact factor: 4.424

7.  Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy.

Authors:  H Nagawa; T Muto; K Sunouchi; Y Higuchi; G Tsurita; T Watanabe; T Sawada
Journal:  Dis Colon Rectum       Date:  2001-09       Impact factor: 4.585

8.  Morbidity and mortality of wide pelvic lymphadenectomy for rectal adenocarcinoma.

Authors:  F Michelassi; G E Block
Journal:  Dis Colon Rectum       Date:  1992-12       Impact factor: 4.585

Review 9.  Training and quality assurance for rectal cancer: 20 years of data is enough.

Authors:  Phil Quirke
Journal:  Lancet Oncol       Date:  2003-11       Impact factor: 41.316

10.  Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers.

Authors:  Toshiaki Watanabe; Giichiro Tsurita; Tetsuichiro Muto; Toshio Sawada; Koki Sunouchi; Yoshiki Higuchi; Yasuhiro Komuro; Takamitsu Kanazawa; Takeru Iijima; Michiko Miyaki; Hirokazu Nagawa
Journal:  Surgery       Date:  2002-07       Impact factor: 3.982

View more
  5 in total

1.  Transanal extended rectal surgery with lateral pelvic lymph node dissection.

Authors:  T Aiba; K Uehara; T Mukai; N Hattori; G Nakayama; M Nagino
Journal:  Tech Coloproctol       Date:  2018-11-27       Impact factor: 3.781

2.  Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.

Authors:  Ipek Sapci; Conor P Delaney; David Liska; Sudha Amarnath; Matthew F Kalady; Scott R Steele; Emre Gorgun
Journal:  J Gastrointest Surg       Date:  2019-04-22       Impact factor: 3.452

3.  Baseline MRI detected lateral lymph node as a prognostic factor: a cohort study in pN0 low-risk rectal cancer.

Authors:  Rui-Jia Sun; Lin Wang; Xiao-Ting Li; Qiao-Yuan Lu; Xiao-Yan Zhang; Zhen Guan; Ying-Shi Sun
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-12       Impact factor: 4.553

4.  Embryological Development and Topographic Anatomy of Pelvic Compartments-Surgical Relevance for Pelvic Lymphonodectomy.

Authors:  Andreas Bayer; Tillmann Heinze; Ibrahim Alkatout; Daniar Osmonov; Sigmar Stelzner; Thilo Wedel
Journal:  J Clin Med       Date:  2021-02-11       Impact factor: 4.241

5.  Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement.

Authors:  Erman Aytaç; Leyla Özer; Bilgi Baca; Emre Balık; Yersu Kapran; Orhun Cığ Taşkın; Başak Oyan Uluç; Mehmet Ufuk Abacıoğlu; Murat Gönenç; Yasemin Bölükbaşı; Barbaros E Çil; Bülent Baran; Cem Aygün; Mehmet Erdem Yıldız; Kemal Ünal; Burçak Erkol; Tunç Yaltı; Uğur Özbek; Tan Attila; Nurdan Tözün; Bengi Gürses; Sibel Erdamar; Özlem Er; Nuran Beşe; Orhan Bilge; Güralp Onur Ceyhan; Nil Molinas Mandel; Uğur Selek; Cengiz Yakıcıer; Hülya Kayserili Karabey; Murat Saruç; Volkan Özben; Eren Esen; Emre Özoran; Erkan Vardareli; Levent Güner; İsmail Hamzaoğlu; Dursun Buğra; Tayfun Karahasanoğlu; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2022-08       Impact factor: 1.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.